OX40 transcriptomic expression and its association with immune checkpoints and clinical outcomes
Therapeutic Advances in Medical Oncology
Published online on July 13, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:Preclinical data suggests a potential role for OX40 agonists in cancer treatment, though clinical trials have yielded modest results.Objectives:We assessed OX40 and other immune checkpoint RNA expression in advanced solid malignancies and their ...
Background:Preclinical data suggests a potential role for OX40 agonists in cancer treatment, though clinical trials have yielded modest results.Objectives:We assessed OX40 and other immune checkpoint RNA expression in advanced solid malignancies and their ...